Conference Description:

Learn from key opinion leaders working to deliver RNA therapies for several therapeutic areas including infectious disease and cardiovascular disease. Across two in-depth sessions the latest improvements pushing the industry forward will be addressed: from RNA formulation strategies, design and development through to antisense and oligo-mediated RNA delivery and improvements in extrahepatic delivery approaches.